Imagotype
Prognostic Factors of Survival in a Randomized Phase III Trial (MPACT) of Weekly <i>nab-</i>Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Pancreatic Cancer | Publicación